adapted application evidence multicenter clinical trial vitamin e slows rate clinical deterioration individuals moderately severe alzheimer disease ad ad cooperative adcs mounting large test effects vitamin e persons earliest stage cognitive deterioration older individuals syndrome ds high risk ad individuals ds develop functional decline show neuropathological evidence ad sixth decade applicants propose international multicenter randomized doubleblind determine whether vitamin e supplementation slow rate cognitivefunctional decline individuals ds subjects ds least 50 years age randomized two treatment groups vitamin e 2000 iu plus multivitamin per day placebo plus multivitamin multivitamin contains vitamin e 15 iu treatment period three years evaluation visits every six months primary outcome measure three year change score cognitivefunctional measure derived purpose dyspraxia scale adults syndrome secondary outcome measures include additional cognitive tests well informantbased measures function behavior